Please assess the completion status of the following clinical trial:

Trial Title: Does the Addition of Epinephrine Prolong the Duration of Spinal Anesthesia for Repeat Cesarean Section?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Non-emergent repeat cesarean section~* Neuraxial anesthesia as the planned primary anesthetic~* Informed consent obtained~* Females age 18-50~Exclusion Criteria:~* Emergency cesarean section~* Anesthetic other than neuraxial~* Allergy to local anesthetics, morphine, or epinephrine~* Pre-existing sensory/motor deficit

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Low-dose epinephrine (Type: EXPERIMENTAL): 100micrograms of epinephrine group
- High-dose epinephrine (Type: EXPERIMENTAL): 200micrograms of epinephrine group
- No epinephrine (Type: PLACEBO_COMPARATOR): 0.2ml saline

Based on this trial design, predict the completion outcome and termination type (if applicable).